About: Nancy Ascher

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Nancy Ascher Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

American organ transplant surgeon

Attributes	Values
rdf:type	Item
owl:sameAs	Nancy Ascher
description	cirujana estadounidense (es) American organ transplant surgeon (en)
rdfs:label	Nancy Ascher (de) Nancy Ascher (en) Nancy Ascher (es) Nancy Ascher (fr) Nancy Ascher (nl) Nancy Ascher (pt) Nancy Ascher (pt-br)
skos:prefLabel	Nancy Ascher (de) Nancy Ascher (en) Nancy Ascher (es) Nancy Ascher (fr) Nancy Ascher (nl) Nancy Ascher (pt) Nancy Ascher (pt-br)
name	Nancy Ascher (de) Nancy Ascher (en) Nancy Ascher (es) Nancy Ascher (fr) Nancy Ascher (nl) Nancy Ascher (pt) Nancy Ascher (pt-br)
given name	wds:Q104177458-105C3526-D816-4AA6-B3C8-0B9369736D82
given name	Nancy
instance of	wds:Q104177458-9dec68ad-f3dc-4f8e-98db-37577bc6032f
instance of	Homo sapiens
Google Knowledge Graph ID	wds:Q104177458-F16A6FF7-4A38-47FC-AAAF-AF42280DFD58
Google Knowledge Graph ID	http://g.co/kg/g/11f50xl1kh
Google Knowledge Graph ID	/g/11f50xl1kh
skos:altLabel	Nancy L Ascher (en) Nancy L. Ascher (en)
sex or gender	wds:Q104177458-8e8dc741-767d-4c05-b08e-7a1ffb414813
family name	wds:Q104177458-2A049999-4894-41A7-AAA9-96954DE3D5BF
sex or gender	female organism
family name	Ascher
is about of	Nancy Ascher https://www.wikidata.org/wiki/Special:EntityData/Q104177458 Nancy Ascher
is author of	Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Hepatitis C Virus Not Found in Fulminant Non-A, Non-B Hepatitis "Occult" hepatitis B virus as source of infection in liver transplant recipients An implantable pump for intrarenal infusion of immunosuppressants in a canine autotransplant model Interferon-alpha therapy for hepatitis C virus infection after liver transplantation The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival Liver transplantation for nonviral, nonmalignant diseases:problem of recurrence Hepatitis B virus and apparent fulminant non-A, non-B hepatitis A randomized trial of exercise and dietary counseling after liver transplantation Physical activity and health-related quality of life in liver transplant recipients Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation Functional analysis of grafts from living donors. Implications for the treatment of older recipients. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function Similar renal allograft functional survival rates for kidneys from sibling donors matched for zero-versus-one haplotype with the recipient Pathological changes in yearly protocol liver biopsy specimens from healthy pediatric liver recipients Outcomes of surgical repair of bile leaks and strictures after adult-to-adult living donor liver transplant Fulminant Wilson's disease treated with postdilution hemofiltration and orthotopic liver transplantation Ultrasound and computed tomographic evaluation in hepatic transplantation. Abdominal sonography after hepatic transplantation: results in 36 patients Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia Recurrent and acquired hepatitis C viral infection in liver transplant recipients Quantitation of hepatitis C virus RNA in liver transplant recipients The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients Cirrhosis of undefined pathogenesis: absence of evidence for unknown viruses or autoimmune processes Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores Maintenance immunosuppression after liver transplantation Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin Interferon alfa for recurrent hepatitis B infection after liver transplantation Azathioprine hepatotoxicity after liver transplantation. Effects of exercise training on coronary heart disease risk factors in renal transplant recipients The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes Cryoglobulinemia presenting after liver transplantation Graft vs. host disease after liver transplantation in humans: A report of four cases Transjugular intrahepatic portacaval stent shunts in patients with renal insufficiency Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophils. Effect of systemic cyclosporine on tumor recurrence after liver transplantation in a model of hepatocellular carcinoma A dendritic cell line genetically modified to express CTLA4-IG as a means to prolong islet allograft survival Death from donor-transmitted malignancy despite emergency liver retransplantation Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria Maintenance immunosuppression with prednisone and RS-61443 alone following liver transplantation. Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Nonoperative management of biliary leaks after orthotopic liver transplantation The use of the T tube after orthotopic liver transplantation

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software